Chloroquine
Chloroquine

0.54
A clinical formulation indicated for Antiparasitics. This product facilitates the disruption of parasitic life cycles to support clearance from the bloodstream.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Chloroquine
Reference Brand
Aralen
Product Origin
Generic Product
Reference Manufacturer
Various generic manufacturers
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Infection Treatment, Infection Treatment
Product Category
Antimalarial
Pharmacological Class
4-aminoquinoline
Off-Label Uses
Manufacturer Description
An antimalarial agent developed to manage malaria infections and intended to alleviate parasitic growth to support patient recovery.
Mechanism of Action
It interferes with the parasite's ability to digest hemoglobin in the host's blood, which leads to the accumulation of toxic heme and parasitic death.
Route of Administration
Oral
Onset Time
Rapid absorption
Duration
Variable (very long half-life)
Contraindications
Retinal or visual field changes, QT prolongation, Allergy to chloroquine
Severe Adverse Events
Irreversible eye damage (Retinopathy), Heart rhythm changes, Seizures, Hearing loss, Severe hypoglycemia
Common Side Effects
Nausea, Stomach upset, Headache
Uncommon Side Effects
Diarrhea, Itching, Dizziness, Blurred vision, Skin rash
Drug Interactions
Antacids, Digoxin, Cimetidine, Amiodarone, QT-prolonging drugs
Pregnancy Safety Warnings
Can be used if benefit outweighs risk.
Age Restrictions
Weight-based dosing for children.
Storage Guidelines
Store at room temperature in a dry place.
Related Products
Hydroxychloroquine, Mefloquine
Information for Chloroquine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories